Chemomab Therapeutics Ltd.
Hedge Funds Holdings

Last updated:

Chemomab Therapeutics Ltd.‘s stocks are currently a part of 4 hedge funds’ portfolios, which represents 0.02% of the total amount of its stocks outstanding. This makes up a total of 35.47K shares of Chemomab Therapeutics Ltd.. Compared to the previous quarter, the number fell by -98.93% or -3.27M shares fewer. As for the holding position changes, 50% (2) of current holders sold a part of the shares held, and 75% (3) closed the holdings completely.

Hedge funds holding Chemomab Therapeutics Ltd. (Q1 2021 – Q1 2023)

Number of hedge funds
Q1 2021 10
Q2 2021 11
Q3 2021 14
Q4 2021 14
Q1 2022 15
Q2 2022 13
Q3 2022 14
Q4 2022 14
Q1 2023 4

Hedge funds changes in Chemomab Therapeutics Ltd. positions (Q1 2021 – Q1 2023)

Changes in positions
Q1 2021 100000
Q2 2021 6135-4
Q3 2021 7144-2
Q4 2021 24422
Q1 2022 6435-3
Q2 2022 24142
Q3 2022 32612
Q4 2022 24224
Q1 2023 0023-1

Top 50 hedge fund holders of Chemomab Therapeutics Ltd. (NASDAQ:CMMB)

Hedge fund Value Shares owned Portfolio share
ORBIMED ADVISORS LLC 6.42M 2.57M 0.119%
CORMORANT ASSET MANAGEMENT, LP 718K 288.16K 0.050%
IKARIAN CAPITAL, LLC 612K 245.89K 0.122%
BOOTHBAY FUND MANAGEMENT, LLC 93K 37.37K 0.002%
STATE STREET CORP 71K 28.64K 0.000%
CITADEL ADVISORS LLC Ken Griffin 53K 21.22K 0.000%
ENVESTNET ASSET MANAGEMENT INC 29K 11.71K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 29K 11.73K 0.000%
ACTIVEST WEALTH MANAGEMENT 19K 7.6K 0.006%
ADVISOR GROUP HOLDINGS, INC. 18K 6.98K 0.000%
MORGAN STANLEY 15K 6.2K 0.000%
UBS GROUP AG 12K 4.88K 0.000%
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. 3K 1.1K 0.002%
ROYAL BANK OF CANADA 1K 246 0.000%
MEITAV INVESTMENT HOUSE LTD 0 0 0.000%